DCS PHARMA: YOUR EXPERT SPECIALISTS FOR ACTIVE PHARMACEUTICAL INGREDIENTS
DCS PHARMA was founded in 2016 by the two Swiss pharmaceutical distributors DOLDER, based in Basel, and CHEMSWISS, based in Baar, Zug. With Dolder bringing over 100 years’ experience in the trade of active ingredients and Chemswiss bringing their experience with hormones and steroids to the table, our intrepid startup is anything but a newcomer.
PRODUCTS IN FOCUS
DCS Pharma portfolio (PDF)
BORTEZOMIB FROM DCS PHARMA USA: US EXCLUSIVITY EXPIRES IN 2022
With earlier than expected entry of the generic into the US, the market potential of Bortezomib is expected to increase significantly. Be the first in the market with our technical and regulatory support.
PEMETREXED: EXTRAORDINARY SUPPORT FOR THIS BLOCKBUSTER
Lung cancer is the most diagnosed cancer worldwide, with of approximately 1.5M new cases annually. Our partner is leading the Chinese FDF/API market since 2007 offering a short lead time, high service level and full technical and regulatory support.
DAPAGLIFLOZIN FROM DCS PHARMA USA: BREAKTHROUGH FOR TYPE-2 DIABETES
We are pleased to introduce Dapagliflozin for the treatment of type-2 diabetes, another DCS Pharma USA solution to maximize your sourcing results.
FLUOROURACIL (5-FU): MAKE THE MOST OF OUR OWN DOCUMENTS (CEP, DMF)
Together with Oxaliplatin and Folinic Acid, 5-FU is used in the most successful first line treatment of colon cancer (FOLFOX). As a second line treatment, it is successfully applied with Folinic Acid and Irinotecan (FOLFIRI). We can provide all these oncological APIs.
MARCH 19-22, 2018
NEW YORK CITY, USA
With us, you can make it anywhere. Let's make an appointment.
MAY 24-26, 2018
PENNSYLVANIA CONVENTION CENTER
Learn more about our commitment to API. Contact us for an appointment.
JUNE 20-22, 2018
Fascinating products and services for a fascinating event.
OCTOBER 9-11, 2018
IFEMA, FERIA DE MADRID
HALL 7 BOOTH 7C80
Meet us at the industry's hottest event.